具有局灶性结节性增生影像学特征的肝内胆管混合性肝癌。
Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia.
作者信息
Willekens Inneke, Hoorens Anne, Geers Caroline, Op de Beeck Bart, Vandenbroucke Frederik, de Mey Johan
机构信息
Department of Radiology, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
出版信息
World J Gastroenterol. 2009 Aug 21;15(31):3940-3. doi: 10.3748/wjg.15.3940.
Abstract
Combined hepatocellular and cholangiocellular carcinoma (cHCC-CC) is a rare tumor type containing unequivocal elements of both hepatocellular carcinoma and cholangiocarcinoma that are intimately mixed. Although these tumors are usually considered to be more related to hepatocellular carcinoma than to cholangiocarcinoma, they sometimes, in contrast to hepatocellular carcinoma, contain a significant amount of fibrous stroma. This might in some cases explain atypical radiological features. We report a case of a cHCC-CC in a 47-year-old female that resembled focal nodular hyperplasia on Magnetic Resonance Imaging. Correlation of imaging and serum levels of alpha-fetoprotein and CA19.9 can help to make the correct diagnosis preoperatively.
摘要
肝内胆管癌合并肝细胞癌（cHCC-CC）是一种罕见的肿瘤类型，同时包含明确的肝细胞癌和胆管癌成分，且两者紧密混合。尽管这些肿瘤通常被认为与肝细胞癌的关系比与胆管癌的关系更为密切，但与肝细胞癌不同的是，它们有时含有大量纤维性间质。这在某些情况下可能解释了其非典型的放射学特征。我们报告一例47岁女性的cHCC-CC病例，该病例在磁共振成像上类似局灶性结节性增生。影像学检查与血清甲胎蛋白和CA19.9水平的相关性有助于术前做出正确诊断。
相似文献
1
Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia.具有局灶性结节性增生影像学特征的肝内胆管混合性肝癌。
World J Gastroenterol. 2009 Aug 21;15(31):3940-3. doi: 10.3748/wjg.15.3940.
2
Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.肝细胞癌与胆管癌混合型（双表型）肿瘤：临床特征、超声造影及计算机断层扫描的影像学特征
BMC Cancer. 2016 Feb 25;16:158. doi: 10.1186/s12885-016-2156-x.
3
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.切除的肝细胞癌合并胆管癌的艾伦C型分类的临床和病理特征：与肝细胞癌和胆管细胞癌的比较研究
J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98. doi: 10.1016/j.gassur.2006.01.018.
4
Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver.非肝硬化肝脏中的肝细胞癌合并胆管细胞癌
J Gastroenterol. 1998 Aug;33(4):593-6. doi: 10.1007/s005350050140.
5
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素：倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
6
Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.混合型肝细胞癌和胆管细胞癌（双表型）肿瘤：增强 CT 和 MRI 的影像学特征和诊断准确性。
AJR Am J Roentgenol. 2013 Aug;201(2):332-9. doi: 10.2214/AJR.12.9488.
7
Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.肝细胞癌合并胆管癌：一例病例报告及文献综述
Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):656-9.
8
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].[双相螺旋CT与MnDPDP增强MRI在肝脏病变检测与特征描述中的比较]
Rofo. 2001 Mar;173(3):266-72. doi: 10.1055/s-2001-11596.
9
Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.超声造影和肿瘤标志物在鉴别肝内胆管癌与肝细胞癌及胆管癌中的潜在诊断效能
J Med Ultrason (2001). 2018 Apr;45(2):231-241. doi: 10.1007/s10396-017-0834-1. Epub 2017 Oct 20.
10
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma?混合性肝癌的免疫形态学和分子生物学：巢蛋白是否是间充质细胞瘤的标志物？
Histopathology. 2020 Jan;76(2):265-274. doi: 10.1111/his.13966. Epub 2019 Oct 29.
引用本文的文献
1
Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.Arg-1、Hep Par-1 和 CK19 表达在原发性肝细胞癌亚型诊断中的作用及对转移瘤的排除。
Histol Histopathol. 2021 Sep;36(9):981-993. doi: 10.14670/HH-18-361. Epub 2021 Jul 13.
2
New insights into the pathophysiology and clinical care of rare primary liver cancers.罕见原发性肝癌病理生理学与临床护理的新见解。
JHEP Rep. 2020 Aug 24;3(1):100174. doi: 10.1016/j.jhepr.2020.100174. eCollection 2021 Feb.
3
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.肝细胞癌的磁共振成像的要点与陷阱。
World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012.
4
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.cHCC-CCA：具有肝细胞和胆管细胞分化的原发性肝癌的共识术语。
Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.
5
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.支持LI-RADS主要特征用于基于CT和MRI成像诊断肝细胞癌的证据：一项系统评价
Radiology. 2018 Jan;286(1):29-48. doi: 10.1148/radiol.2017170554. Epub 2017 Nov 21.
6
Current update on combined hepatocellular-cholangiocarcinoma.肝细胞胆管癌联合诊疗的最新进展
Eur J Radiol Open. 2014 Sep 6;1:40-8. doi: 10.1016/j.ejro.2014.07.001. eCollection 2014.
7
Role of liver stem cells in hepatocarcinogenesis.肝干细胞在肝癌发生中的作用。
World J Stem Cells. 2014 Nov 26;6(5):579-90. doi: 10.4252/wjsc.v6.i5.579.
8
Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report.肝移植后肝细胞癌与胆管癌同时发生（碰撞瘤）：一例报告
Hepat Mon. 2012 Oct;12(10 HCC):e5871. doi: 10.5812/hepatmon.5871. Epub 2012 Oct 28.
本文引用的文献
1
Management of combined hepatocellular and cholangiocarcinoma.肝细胞癌合并胆管癌的管理
Int J Clin Pract. 2008 Aug;62(8):1271-8. doi: 10.1111/j.1742-1241.2007.01694.x. Epub 2008 Feb 13.
2
Combined liver cell and bile duct carcinoma.肝细胞胆管癌合并症
Am J Pathol. 1949 Jul;25(4):647-55.
3
Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.肝细胞胆管癌：通过计算机断层扫描/磁共振成像研究的预后因素
Int J Clin Pract. 2008 Aug;62(8):1199-205. doi: 10.1111/j.1742-1241.2007.01291.x. Epub 2007 May 30.
4
Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography.增强计算机断层扫描下肝细胞-胆管癌的复发模式
J Comput Assist Tomogr. 2007 Jan-Feb;31(1):109-15. doi: 10.1097/01.rct.0000235072.34808.9b.
5
Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.肝细胞癌合并胆管癌与肝细胞癌及肝内胆管癌的比较。
Surg Today. 2006;36(10):892-7. doi: 10.1007/s00595-006-3276-8.
6
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.切除的肝细胞癌合并胆管癌的艾伦C型分类的临床和病理特征：与肝细胞癌和胆管细胞癌的比较研究
J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98. doi: 10.1016/j.gassur.2006.01.018.
7
A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection.11 例肝细胞癌-胆管细胞癌合并症的临床研究：切除前动态计算机断层扫描增强模式评估。
Hepatol Res. 2005 Jul;32(3):185-95. doi: 10.1016/j.hepres.2005.04.003. Epub 2005 Jun 22.
8
Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.增强CT对肝细胞癌合并胆管癌的诊断：与组织学结果的比较
AJR Am J Roentgenol. 2005 Apr;184(4):1157-62. doi: 10.2214/ajr.184.4.01841157.
9
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.肝细胞胆管癌的临床病理特征及预后
Am J Surg. 2005 Jan;189(1):120-5. doi: 10.1016/j.amjsurg.2004.03.018.
10
Combined hepatocellular-cholangiocarcinoma: a case report.肝内胆管癌合并肝细胞癌：一例报告
Int J Clin Pract. 2004 Dec;58(12):1170-3. doi: 10.1111/j.1742-1241.2004.00110.x.
Zotero 插件